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Cotranscriptional ubiquitination of histone H2B is key to gene reg-
ulation. The yeast E3 ubiquitin ligase Bre1 (human RNF20/40) pairs
with the E2 ubiquitin conjugating enzyme Rad6 to monoubiquiti-
nate H2B at Lys123. How this single lysine residue on the nucleo-
some core particle (NCP) is targeted by the Rad6–Bre1 machinery is
unknown. Using chemical cross-linking and mass spectrometry, we
identified the functional interfaces of Rad6, Bre1, and NCPs in a
defined in vitro system. The Bre1 RING domain cross-links exclu-
sively with distinct regions of histone H2B and H2A, indicating a
spatial alignment of Bre1 with the NCP acidic patch. By docking
onto the NCP surface in this distinct orientation, Bre1 positions the
Rad6 active site directly over H2B Lys123. The Spt–Ada–Gcn5 ace-
tyltransferase (SAGA) H2B deubiquitinase module competes with
Bre1 for binding to the NCP acidic patch, indicating regulatory con-
trol. Our study reveals a mechanism that ensures site-specific NCP
ubiquitination and fine-tuning of opposing enzymatic activities.
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RING E3 ligase
Eukaryotes organize their DNA into chromatin, which pack-ages DNA while allowing coordinated gene expression. The
basic unit of the chromatin polymer is the nucleosome core
particle (NCP), formed by an octameric complex of core histones
(two copies each of H2A, H2B, H3, and H4) that is encircled by
145–147 bp of DNA (1). A large set of chromatin factors “write,”
“read,” or “erase” histone posttranslational modifications and
thereby alter the transcriptional properties of chromatin (2). The
∼200 kDa NCP provides a varied interaction surface for chro-
matin factors through the flexible histone N- and C-terminal
tails, the rigid disk faces of the histone octamer, and the nucle-
osomal DNA (3). The recognition of unstructured histone tails
by numerous protein domains is well studied, but far less is
known about how chromatin factors recognize the disk face of
the NCP. Monoubiquitination of histone H2B occurs at lysine
123 (H2B Lys123∼Ub) in yeast (equivalent to mammalian
Lys120). The enzymatic reaction is carried out by the E3 ligase
Bre1 (human RNF20/40) together with the E2 enzyme Rad6
(4–7). This highly site-specific ubiquitination of H2B controls
various aspects of gene expression, which include transcription
initiation and elongation (8), DNA replication (9) and repair
(10), and kinetochore function (11). H2B Lys123∼Ub is thought
to exert its effects through altering chromatin compaction and by
promoting specific histone H3 methylations (12, 13). H2B
ubiquitination is reversed by a heterotetrameric deubiquitinase
module, which is part of the Spt–Ada–Gcn5 acetyltransferase
(SAGA) complex (14, 15). Aberrant H2B Lys123∼Ub levels are
observed in various disease states (16), suggesting that the fine-
tuning of opposing ubiquitin ligase and deubiquitinase activities
is critical for normal cell function.
Ubiquitination involves a three-step enzymatic reaction re-
quiring ubiquitin-activating (E1), ubiquitin-conjugating (E2),
and ubiquitin-ligating (E3) enzymes (17). Most E3 ligases use a
RING domain to activate an E2∼ubiquitin thioester and mediate
ubiquitin transfer to a substrate (“∼” denotes a covalent and “–”
denotes a noncovalent interaction). The E3 RING domain, the
E2, and ubiquitin interact with each other to stabilize a confor-
mation that primes the thioester bond for nucleophilic attack
by the substrate lysine residue (18). The Rad6–Bre1 machinery is
unusual insofar as Rad6 interacts canonically with the Bre1
RING and through its “backside” with a separate non-RING
domain of Bre1, which can potentiate ubiquitin transfer to the
substrate (19).
After decades of research on H2B Lys123∼Ub (20), it is still
unclear how the Rad6–Bre1 machinery exclusively targets H2B
Lys123 but no other histone lysine residues on the NCP (21). It
was previously suggested that acidic histone residues are re-
quired to maintain normal cellular H2B∼Ub levels in Saccha-
romyces cerevisiae (22, 23). However, it has remained unclear
whether those residues mediate a direct physical interaction with
Rad6–Bre1, or whether their mutation indirectly perturbs chro-
matin architecture or affects other transcription components.
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Now, by using cross-linking and mass spectrometry (XL-MS) we
have succeeded in biochemically capturing the transient Bre1–
NCP interaction and elucidating how this dictates Rad6 lysine
specificity. We further establish how Bre1 directly recognizes the
NCP disk surface in opposition to the SAGA H2B deubiquiti-
nase module. Our study is fundamental for understanding the
molecular basis of H2B ubiquitination in yeast and metazoa.
Results
Bre1–NCP Interaction Topology Determined by XL-MS. To map the
NCP interaction sites of Rad6 and Bre1, we used a recombinant
Rad6∼Bre1 fusion, in which the C terminus of Rad6 was con-
nected to the N terminus of the Bre1 eRING domain (extended
RING; amino acids 568–700) via a flexible linker (Fig. 1A,
lane1). This minimal construct specifically modifies H2B Lys123
and is biochemically stable (19). The fusion protein is more ac-
tive than full-length Bre1 and Rad6 alone in an in vitro NCP
ubiquitination assay, likely because the transient RING–E2 in-
teraction is stabilized. We used NCPs reconstituted from poly-
cistronically expressed yeast histones in Escherichia coli and the
Widom 601 DNA sequence as a substrate. Titrating increasing
amounts of the homobifunctional cross-linker DSS (dis-
uccinimidyl suberate) to a 1:1 molar mixture of Rad6∼Bre1 and
NCP lead to the formation of high molecular weight complexes
(Fig. 1A and Fig. S1A). DSS induces nucleophilic attacks on
primary amines and thereby couples lysine residues. Notably, of
all histone proteins, histone H2B was preferentially cross-linked
with increasing amounts of DSS (compare histone stoichiometry,
e.g., lane 2 vs. 5 in Fig. 1A), which parallels the reduction and
upward shift of Rad6∼Bre1. This finding indicates a preferential
cross-linking and hence spatial proximity between Rad6∼Bre1
and the target protein. Subsequent MS analysis revealed 94 high-
confidence interlinks and 100 intralinks among histones (Fig.
S1B and Dataset S1). Ninety-eight intralinks were identified
within Rad6∼Bre1 (Fig. 1B and Dataset S1), consistent with the
previously reported direct interaction between Rad6 and the
Bre1 eRING domain (19) as well as Bre1 homodimerization
(24). Of significance, only two unique interlinks between
Rad6∼Bre1 and the NCP were identified (Fig. 1B). These high-
confidence linkages correspond to a single peptide within the
Bre1 RING domain that cross-links exclusively to two different
peptides within histone H2B and H2A. No cross-links between
Rad6 and histones were found. The H2B peptide maps to the
C-terminal α-helix of the protein, which harbors the Lys123
ubiquitination site, and is located surface-exposed at the DNA
edge opposite of the NCP dyad. The cross-linked H2A peptide
maps to a C-terminal extension at the opposite DNA edge next
to the NCP dyad. Notably, despite the large number of available
lysine residues in the NCP (114 Lys in total, including 54 Lys in
the tails), only two lysines were specifically cross-linked to Bre1.
This finding suggests that the E3 binds in a defined orientation
on the disk face of the NCP. The cross-linking of one Bre1
peptide to two different histone peptides is consistent with the
symmetric arrangement and the overall size of the dimeric RING
domain (24), as one RING monomer could contact H2B and the
other H2A. A line drawn between the identified H2A and H2B
peptides (Fig. 1B) runs directly over a prominent feature of the
NCP surface, the acidic patch, a groove formed by conserved
aspartate and glutamate residues from H2A and H2B (Fig. 1C).
Remarkably, the Bre1 RING domain features four highly con-
served basic residues, which are surface-exposed (24) and could
readily direct Bre1 to the NCP acidic patch. Taken together, the
XL-MS–derived spatial restraints suggested a specific interaction
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Fig. 1. Bre1–NCP interaction topology determined by XL-MS. (A) Titration
of DSS to recombinant Rad6∼Bre1 and NCP (S. cerevisiae proteins mixed at a
1:1 molar ratio). Samples were separated by SDS/PAGE (4–12%, MOPS buffer)
and stained by Coomassie. DSS at 0.24 mM was chosen for further XL-MS
analysis. (B) XL-MS analysis revealed Rad6∼Bre1 intralinks and interlinks with
NCP (red lines). Yeast NCP (PDB ID code 1ID3) is depicted in surface repre-
sentation when viewed down the DNA superhelical axis. Sequences of cross-
linked Bre1 and histone peptides with amino acid position of Lys residues are
indicated. Peptides (red) were mapped onto the NCP surface. H2B Lys123 is
labeled in orange; all other NCP Lys residues visible in the structure are in
green. The C terminus of H2A is only partially resolved (dashed line). Dotted
white line represents the axis between cross-linked H2B and H2A peptides.
NCP dyad axis is indicated as a reference. (C) NCP electrostatic surface po-
tential (negative in red, positive in blue) highlights the NCP acidic patch
formed by H2A/H2B residues. Axis of cross-linked peptides as in B. H2B
Lys123 is also indicated.



















basic RING and acidic NCP residues, a hypothesis that we tested
further, as described below.
The NCP Acidic Patch Directly Recruits Bre1 to Monoubiquitinate H2B.
To determine whether Bre1 directly binds the NCP acidic patch,
we first attempted to inhibit the interaction with a viral peptide
that targets the same region. The N terminus of the herpes virus
latency-associated nuclear antigen (LANA) forms a hairpin that
inserts into the H2A/H2B acidic patch as seen in the LANA–
NCP cocrystal (25). Of note, the overall structure of the NCP is
not perturbed by LANA binding. Increasing amounts of a 23-
residue LANA peptide blocked binding of full-length Bre1 to the
NCP in pull-down assays, consistent with LANA obstructing Bre1
access to the acidic patch. In contrast, a mutant LANA peptide
(L8R9S10 > AAA) with a reduced acidic patch affinity (25) was less
efficient in competing with Bre1 for NCP binding (Fig. 2A). As a
result of the impaired NCP interaction, Bre1 exhibited a reduced
H2B monoubiquitination activity in an in vitro assay, whereas the
mutant LANA peptide had little inhibitory effect (Fig. 2B). These
results demonstrate that an accessible acidic patch is required for
efficient NCP recognition and ubiquitination of H2B Lys123. To
corroborate these findings, we reconstituted NCPs carrying point
mutations in key acidic residues. Notably, alanine substitutions of
H2A Glu57 and H2B Glu116, which lie close to the target Lys123
(Fig. 1C), impaired Bre1 binding to the mutant NCP and this
effect was enhanced when both mutations were combined (Fig.
2C). Consequently, all these acidic patch mutations inhibited
H2B monoubiquitination in vitro (Fig. 2D). This finding dem-
onstrates that an accessible and intact acidic patch is required
for Bre1 recruitment to the NCP in agreement with the in-
teraction topology obtained by XL-MS.
XL-MS Captures the Transient Bre1 RING–Rad6 Interaction. A key
question that emerges is how electrostatic interactions between
Bre1 and the NCP, spatially distinct from the site of catalysis,
would position Rad6 such that it targets Lys123, yet no other
histone Lys residue. The Bre1 RING domain directly interacts
with Rad6 and is sufficient to monoubiquitinate H2B Lys123
in vitro (19). We used the known crystal structures of the Bre1
RING domain and Rad6 to generate a homology model of the
E2–E3 complex (24, 26). Superposition of Bre1 RING and Rad6
onto the cCbl–UbcH7 crystal structure (27), followed by super-
position onto RNF4–UbcH5∼Ub (18) generated a dimeric Bre1
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Fig. 2. The NCP acidic patch directly recruits Bre1. (A) The LANA peptide
competes with Bre1 for interaction with the NCP acidic patch. In vitro
binding assays with recombinant NCPs immobilized on anti-Flag beads and
recombinant full-length Strep-tagged Bre1 incubated in a 1:3 molar ratio
(NCP:Bre1). LANA (lanes 2–5) or a LANA_LRS > AAA peptide (lanes 6–9),
mutated in critical NCP-interacting residues (25), were added with increasing
concentrations (20, 40, 60, 80 μM). Following elution, anti-Strep immuno-
blotting was used to detect NCP-bound Strep–Bre1. Anti-Flag detection
confirmed equal input of NCPs. The asterisk indicates an H2B degradation
product. (B) H2B Lys123∼Ub by Bre1 requires an accessible NCP acidic patch.
In vitro NCP ubiquitination assay was performed in the presence of LANA
(lanes 3–6) or a LANA_LRS > AAA peptide (lanes 7–10) (20, 40, 60, 80 μM
peptide). Anti-Flag immunoblotting detects both H2B and H2B Lys123∼Ub.
(C) NCP acidic patch mutations impair Bre1 recognition. In vitro binding
assay with NCP wild-type or different NCP mutants carried out as in A. Input
of mutant NCPs shows their intact stoichiometry. (D) NCP acidic patch mu-
tations affect H2B Lys123∼Ub. In vitro NCP ubiquitination assay with wild-









































Fig. 3. Bre1 RING-Rad6 complex based on XL-MS and homology modeling.
(A) Ribbon representation of the modeled S. cerevisiae Bre1 RING domain
(yellow) interaction with Rad6 (purple). See Fig. S2A for further details on
modeling templates and a version that includes ubiquitin. Zinc ions are
shown as gray spheres. The Rad6 active site is marked as a yellow stick. The
Rad6 N-terminal helix 1 (H1) and loops L4 and L7 comprise the canonical
E3-binding site. Cross-linked peptides (Bre1 in green; Rad6 in cyan) were
mapped onto the structure and their sequences are indicated with the
same color code, including amino acid position of cross-linked Lys residues.
Boxed region is magnified in B. (B) Close-up of the predicted Bre1 RING–
Rad6 interface highlighting cross-linked peptides in Bre1 (green) and Rad6
(cyan). Side-chains of relevant residues are shown in stick representation
and measured distances between cross-linked lysines are indicated.
(C ) Sequence alignment of Bre1 RING domain orthologs from S. cerevisiae,
Candida glabrata, Gallus gallus, Drosophila melanogaster, Mus musculus,
and Homo sapiens. Zinc-coordinating residues are labeled in red. Asterisks
indicate the position of residues involved in Bre1 RING-Rad6 interaction.
The alignment was generated with ClustalW and colored in Jalview by
identity. Numbers refer to S. cerevisiae Bre1 residues.


























and Fig. S2A). Importantly, the interface between Rad6 and the
Bre1 RING in our model is in agreement with XL-MS–derived
contact points. Notably, a single Rad6 peptide that maps to loop 4
(L4), cross-linked to two peptides located on the opposite Bre1
RING surface. The measured distance between cross-linked lysine
residues in the Bre1–Rad6 model satisfies the maximal distance
restraints imposed by the DSS cross-linker (<26 Å between Cα
atoms) (28) (Fig. 3B) and supports the validity of the model.
Other cross-links between Rad6 and Bre1 include peptides that
are not present in the partial Bre1 structure (e.g., Bre1 residues
568–623) (24). Taking these data together, we find that XL-MS
enabled us to monitor the highly dynamic E3–E2 interaction,
providing concise spatial restraints for the Rad6–Bre1 interface.
Specific Bre1 Residues Required for Rad6 Activation and NCP
Recognition. We next sought to validate the E2–E3 interface by
mutating conserved Bre1 amino acids while leaving the struc-
turally relevant zinc-coordinating residues intact. After screening
an extensive number of recombinant constructs, we finally suc-
ceeded in generating stable Leu650 > Ala and Arg675 > Asp
mutants of Bre1, both of which map to the predicted Rad6 in-
terface (Figs. 3B and 4A). To directly measure their effect on
Rad6 activation, we analyzed the discharge of the ubiquitin
thioester (∼Ub) from the active site of Rad6 in single turnover
assays (Fig. 4A, Right, and Fig. 4B). To this end, Rad6 was
charged with ubiquitin by the E1 enzyme and ATP and then
treated with EDTA to inhibit recharging. Rad6 is known to
undergo spontaneous Ub discharge independently of Bre1 over
time (Fig. 4A, Right, compare lane 1 and 3; and Fig. 4B) (19, 29).
However, adding a wild-type Bre1 eRING (amino acids 494–
700) significantly accelerated the reaction. In contrast, Ub dis-
charge was impaired in the Bre1 Arg675 > Asp and to a lesser
extent in the Leu650 > Ala mutant. The involvement of Arg675
suggests a complementary charge on the Rad6 side. Indeed, three
acidic Rad6 residues (Asp60, Glu61, and Glu62) are located
within the cross-linked peptide on loop L4, ∼10–13 Å away from
Arg675 in our model (Fig. S2B). Reduced Ub discharge from
Rad6 could arise from a decreased affinity of Rad6 toward the
Bre1 RING mutants. Alternatively, the mutant RING domains
may specifically affect Rad6 activation. To distinguish between
these possibilities, we performed in vitro binding assays. Notably,
Rad6 binding to the Bre1 RING mutants was not perturbed (Fig.
4C and Fig. S2C). Thus, we conclude that these Bre1 RING
residues are required for stimulating Rad6 catalytic activity,
possibly through an allosteric effect. Whereas Bre1 Arg675 is
located on a short α-helix with its side chain pointing laterally
toward Rad6, three other conserved basic residues (Arg679,
Arg681, Lys682) are part of a surface-exposed loop with their
side chains oriented toward the “base” of the Bre1 RING
homodimer (24) (Fig. 3 B and C). To pinpoint the function of
single residues to Rad6 activation and NCP recognition, we
analyzed them individually by inverting their charge. Notably,
mutation of the basic Bre1 RING residues affected NCP rec-
ognition and the combined Arg681/Lys682 > Asp mutant
exhibited the strongest loss of affinity (Fig. 4D), likely caused by
an electrostatic repulsion with the NCP acidic patch. Interestingly,
the Leu650 > Ala and Arg675 > Asp mutants were defective in
both Rad6 activation and NCP recognition. This result could re-
flect an allosteric coupling of substrate recognition with ubiquitin
discharge or other structural rearrangements. As a consequence of
perturbing the NCP–RING interface, H2B ubiquitination was
impaired in an in vitro assay (Fig. 4E). In sum, we could identify
specific Bre1 residues required for Rad6 activation and NCP
recognition, which are located at the protein interfaces suggested
by XL-MS.
A Model for the E3–E2∼Ub–NCP Complex. To integrate our experi-
mental data, we sought to develop a structural model of the
enzyme-substrate complex that fulfills the constraints derived
from XL-MS, mutational analyses, and the general E2 catalytic
mechanism. We used the Bre1 RING homodimer modeled in
contact with one Rad6∼Ub under the assumption that only a
single Rad6 will target H2B Lys123 (18). The complex was
manually docked onto the NCP disk surface by apposing the
critical basic Bre1 Arg679 and Arg681 residues to H2B Glu116,
an acidic patch residue required for the direct interaction with
Bre1 (Fig. 2C). Next, the Bre1 RING–Rad6∼Ub was rotated
around the DNA superhelical axis of the NCP to approach the
catalytic center of Rad6 (Cys88) toward the H2B Lys123 target
residue (Fig. 5 A and B). This model was refined using all-atom
energy minimization and subsequent molecular dynamics (MD)
equilibration in explicit solvent. Notably, the resulting structural
model brings the Rad6 catalytic Cys88 within a 10.6-Å distance
to the H2B Lys123 (Fig. S3A). This is the closest distance of
Cys88 to any histone Lys residue in its vicinity. Taking the in-
trinsic flexibility of the complex into account, this distance is
reasonably close to a 3–3.5 Å upper limit for a ubiquitin transfer
reaction to happen. Importantly, our model is in excellent
agreement with all XL-MS distance restraints and lends strong
support to the suggested mechanism for H2B Lys123 ubiquiti-
nation and recognition of the acidic patch.
The NCP Acidic Patch Recruits Opposing Enzymatic Activities.Cellular
H2B Lys123∼Ub levels likely reflect the balance of ubiquitin li-
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Fig. 4. Bre1 residues required for Rad6 activation and NCP recognition.
(A) Representative immunoblot of a single turnover ubiquitin discharge
experiment, in which precharged Rad6∼Ub was incubated without Bre1 or
with 100 μM of wild-type or mutant Bre1 eRING. Reactions were stopped
after 0, 10, and 20 min by denaturation. Samples were separated by non-
reducing SDS/PAGE (12% gel, MES buffer) followed by anti-His immuno-
blotting. Bre1 proteins are shown (Left). (B) Quantification of single turnover
experiments as shown in A. Intensity of the Rad6∼Ub and Rad6 bands were
quantified with the ImageLab 1.5.2 software. The ratio between Rad6∼Ub and
Rad6 was calculated for every condition and time 0 was used for normaliza-
tion. Four independent experiments were performed. Mean and SD are in-
dicated. (C) Bre1 RING mutants are not impaired in Rad6 binding. GST–Rad6
was immobilized on GSH beads and incubated with Bre1 eRING constructs in a
1:5 molar ratio. Recombinant GST was used as negative control. After elution,
bound proteins were detected by anti-Strep immunoblotting. See Fig. S2C for
protein input. (D) Specific RING domain mutations impair NCP recognition. In
vitro binding assay with NCPs immobilized on anti-FLAG beads and Bre1
constructs added in 1:3 molar ratio (NCP:Bre1). After elution, immunoblotting
was used to detect NCP-bound Bre1 and equal NCP loading. Input for
recombinant Bre1 proteins is shown (Lower). (E) In vitro NCP ubiquitination
assay performed with the indicated Bre1 mutants.



















whether the NCP acidic patch can regulate recruitment of com-
peting enzymes. We previously implicated solvent-exposed basic
residues on the SAGAH2BDUBmodule (Ubp8–Sgf11–Sgf73–Sus1)
in NCP recognition (14). These basic residues map to a small
ZnF domain of the DUB subunit Sgf11 and were recently con-
firmed to target the NCP surface, specifically the NCP acidic
patch (30). In light of our findings on Rad6–Bre1, we sought to
test whether basic residues on Bre1 and Sgf11 indeed compete
for binding to the NCP acidic patch in solution. Thus, we carried
out NCP ubiquitination reactions in the presence of Sgf11, which
forms a stable heterodimer with Sus1 (14) (Fig. 5C). Notably,
this DUB subcomplex could effectively inhibit H2B ubiquitina-
tion by Bre1–Rad6. In contrast, Sgf11 failed to inhibit the re-
action when Arg84 and Arg91 were mutated, consistent with
their requirement for NCP acidic patch recognition (Fig. 5C).
These observations led us to test whether the NCP acidic patch
mediates the functional opposition between Rad6–Bre1 and the
SAGA DUB module in vivo. To this end, we assessed global
histone H2B∼Ub levels in selected acidic patch mutants in
S. cerevisiae. The H2B Glu116 > Ala mutant recapitulates the
ubiquitination defect seen in vitro. This result is also observed
upon mutating H2A Glu93, a residue located toward the center
of the NCP disk (Figs. 1C and 5D, lanes 2 and 6), and is
consistent with a previous report (23). In marked contrast, H2A
Glu57 and Glu65 mutations showed increased H2B Lys123∼Ub
levels. This result is different from our in vitro finding in which
the H2A Glu57 mutant exhibited reduced Bre1 binding and H2B
ubiquitination (compare Figs. 2D, lane 2, and 5D, lane 3). This
interesting observation can be explained by an interference be-
tween H2B DUB and E2/E3 activities, which are only uncovered
in an in vitro system that lacks DUB activity. Remarkably, both
enzymes target the NCP acidic patch, but some residues, like H2A
Glu57 andGlu65, appear to be more important for DUB than E2/E3
recruitment (Fig. S3 C and D). Of note, our in vivo result on H2A
Glu65 is consistent with a key structural role of this residue in
contacting the basic surface of the Sgf11 ZnF, which is also im-
portant for H2B deubiquitination in vitro (30) (Fig. S3D). In sum,
we establish a molecular mechanism for Rad6–Bre1 recruitment
to the NCP acidic patch that occurs in competition with specific
elements of the SAGA deubiquitinase.
Discussion
Despite the importance of cotranscriptional H2B ubiquitination
for gene expression, the most basic aspects of the reaction, in-
cluding substrate recognition and site-specific ubiquitin transfer,
were poorly understood. Here, we used XL-MS to capture to-
pologically complex relationships between the NCP and the
Rad6–Bre1 ubiquitination machinery in their native state, which
allowed us to identify the E3, E2, and NCP surfaces critical for
specificity and activity. By integrating different experimental
constraints, we derive a precise molecular mechanism in which
the Bre1 RING homodimer uses an arginine motif to interact
with the NCP acidic patch. This positions Rad6 directly above
the ubiquitination site and enables exclusive modification of
H2B Lys123, despite the large number of lysine residues on the
NCP disk surface and flexible histone tails.
A comparison of Bre1–Rad6 with the H2A Lys119 ubiquitinating
module of the polycomb repressive complex 1 (PRC1) highlights
interesting similarities and differences (31). This study reported the
crystal structure of the human Ring1B–Bmi1 E3 ligase fused to the
E2 enzyme UbcH5c in complex with the Xenopus laevis NCP. Re-
markably, the E3 also employs an arginine motif to interact with the
NCP acidic patch and this orients the E2’s active site toward the
target lysine. Although the principle of NCP recognition looks
similar for Bre1, the overall geometry of the E3–E2–NCP complex
is entirely different. H2B Lys123 (Lys120 in humans) is located on
the opposite DNA edge of the NCP disk, compared with the Lys
residue targeted by PRC1. To reach Lys123, Bre1–Rad6 is rotated
by about 180° against the PRC1 E3–E2 complex, when viewed
down the DNA superhelical axis (Fig. S3B), which is remarkable
given that both E3–E2 complexes use the same acidic groove as an
attachment site. The large-scale reorientation of Rad6–Bre1 versus
PRC1 clearly shows that acidic patch interactions per se do not
dictate the selection of an NCP ubiquitination site. In fact, all NCP–
protein complexes that have been structurally determined so far use
positively charged residues on multiple types of secondary struc-
tures as molecular anchors to bind to the NCP acidic patch (3).
All currently available cocrystal structures depicting proteins
bound to the NCP acidic patch are derived from functionally
unrelated factors from divergent species (3). A key insight of our
study is that interference can exist in the same pathway and
species. We find that the yeast H2B ubiquitination machinery
uses an overlapping NCP binding surface with the yeast SAGA
H2B deubiquitinating module (Fig. S3 C and D). Intriguingly,
the DUB also contacts the NCP acidic patch via an arginine
cluster on the Sgf11 zinc finger (30) and we show that Rad6–
Bre1 effectively compete with the Sgf11 zinc finger for binding to
the NCP acidic patch. This finding raises important questions:
Why do both enzymes use the same binding surface? And how is
the interaction of opposing enzymatic activities with the NCP
regulated? An overlapping recognition surface may serve to
avoid unproductive interference of enzymatic activities and also
to enable the fine-tuning of cellular H2B∼Ub levels, which is
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Fig. 5. Model of Bre1 RING–Rad6∼Ub interaction with the NCP. (A) Orthogonal
view of the E3–E2∼Ub complex that was manually docked onto the NCP acidic
patch and subjected to energy minimization andMD equilibration. H2B Lys123 is
labeled in orange. The Rad6 active site (Cys88) is depicted as a yellow sphere.
(B) View of the complex looking down on the DNA superhelical axis. The electro-
static surface potential of the histone octamer (negative in red, positive in blue) is
indicated. Basic residues at the “base” of the RING domain (Arg679, Arg681, and
Lys682) are labeled as blue spheres. The estimated Cα cross-linking distances
between Bre1 Lys682 and the H2A peptide are 22.6 Å (Bre1 Lys682–H2A Thr125;
note that cross-linked H2A Lys126 is not resolved in the NCP structure) and 15.1 Å
for Bre1 Lys682 and H2B Lys123. (C) Bre1 competes with the Sgf11 ZnF for rec-
ognition of the NCP acidic patch. In vitro NCP ubiquitination assay was per-
formed in the presence of wild-type or mutant GST–Sgf11–Sus1 (60 μM).
Reactions were incubated for 60 min and analyzed by SDS/PAGE and immu-
noblotting. Input for Sgf11–Sus1 constructs is shown (Right). (D) Global H2B
Lys123∼Ub levels depend on an intact NCP acidic patch. Cell lysates from
S. cerevisiae strains with Flag-tagged histone H2B were subjected to anti-Flag
immunoprecipitation. Recovered proteins were detected by immunoblotting.


























wide-occupancy of Bre1 on chromatin is determined by the kinetics
of RNA polymerase (Pol) II elongation. The prevailing model is
that Rad6 and Bre1 are physically tethered to the transcribing
Pol II through the conserved Paf1 adaptor complex (32). SAGA
is primarily considered as a promoter-bound coactivator, but a
fraction may also associate with elongating RNA Pol II (33). In
vivo measurements of eukaryotic transcription elongation have
estimated a Pol II speed of up to 5,000 bases per minute (34).
This finding implies that Pol II elongation rate could be a key
rate-limiting step of H2B ubiquitination as each encounter between
Pol II and an NCP opens only a short window of opportunity for
substrate recognition and ubiquitin transfer (35). The highly specific
substrate-targeting mechanism discovered in this study should be
important to ensure efficient H2B∼Ub in the context of a moving
polymerase and in competition with SAGA DUB activity. More-
over, a SAGA-occupied and previously deubiquitinated nucleosome
(e.g., at the promoter) may only be available for reubiquitination
upon dissociation of SAGA.
In this study, we have identified the basic mechanism of NCP
recognition and modification by Bre1–Rad6. Given the conservation
of critical residues, the mechanism is likely conserved between eu-
karyotes. The future challenge is to understand how Bre1 and Rad6
execute a constrained enzymatic reaction while “riding” on the Pol II
machine and to elucidate how opposing enzymatic activities are reg-
ulated to achieve precise spatiotemporal control of gene expression.
Materials and Methods
Constructs of Rad6, Bre1, Sgf11, ubiquitin, and histoneswere cloned, expressed,
and purified as described previously (14, 19). NCPs were reconstituted from
histone octamers and the 167-bp 601 WIDOM positioning sequence. Point
mutations were generated by PCR-based methods and confirmed by se-
quencing. Cross-linking analysis of Rad6∼Bre1 RING:NPC was performed by
mixing purified components in a 1:1 molar ratio with an equimolar mixture of
light and heavy-labeled (deuterated) disuccinimidyl suberate DSS-H12/D12
(Creative Molecules). A final concentration of 0.24 mM DSS was used for cross-
linking at 30 °C for 30 min. The reaction was quenched by the addition of final
100 mM ammonium bicarbonate and samples were processed by MS. In vitro
ubiquitination assays, binding assays and E2 discharging assays were per-
formed essentially as described previously (19). Immunoprecipitation of FLAG-
tagged histone H2B was performed as described previously (14). A manually
assembled configuration of the Bre1–Rad6/nucleosome core particle complex
was refined using all-atom energy minimization and subsequent MD equili-
bration. Full experimental details are available in SI Materials and Methods.
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